Focusing on Leadership

2002 was a year of tremendous accomplishments for Boston Scientific. We worked hard. We challenged ourselves. We accepted nothing but the best. We reestablished our position in the coronary stent market with a highly competitive and anticipated stent. We also introduced our next-generation coronary angioplasty balloon and leveraged our stent technologies across clinical applications only a year after the first generations became available. As a result, at the end of 2002 we had regained leadership in the cardiovascular and peripheral vascular catheter labs with a 31 percent worldwide market share.

We are excited by our prospects for 2003. However, it is the progress that we made in 2002 and recent years that have opened the door to the new growth opportunities that
lie ahead.